A carregar...
Immunomodulation Followed by Antigen-Specific T(reg) Infusion Controls Islet Autoimmunity
Optimal immune-based therapies for type 1 diabetes (T1D) should restore self-tolerance without inducing chronic immunosuppression. CD4(+)Foxp3(+) regulatory T cells (T(regs)) are a key cell population capable of facilitating durable immune tolerance. However, clinical trials with expanded T(regs) in...
Na minha lista:
| Publicado no: | Diabetes |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6971488/ https://ncbi.nlm.nih.gov/pubmed/31712320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db19-0061 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|